(Q39464875)

12 September 2017

Tissue transglutaminase links TGF-β, epithelial to mesenchymal transition and a stem cell phenotype in ovarian cancer (English)

1 reference

12 September 2017

1 reference

1 reference

L Cao

1

1 reference

12 September 2017

M Shao

2

1 reference

12 September 2017

J Schilder

3

1 reference

12 September 2017

T Guise

4

1 reference

12 September 2017

K S Mohammad

5

1 reference

12 September 2017

D Matei

6

1 reference

12 September 2017

language of work or name

English

0 references

publication date

3 October 2011

1 reference

12 September 2017

1 reference

12 September 2017

31

1 reference

12 September 2017

20

1 reference

12 September 2017

2521-2534

1 reference

https://scigraph.springernature.com/pub.10.1038/onc.2011.429

12 September 2017

0 references

cites work

Regulation of transforming growth factor-beta secretion by human peritoneal mesothelial and ovarian carcinoma cells

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Cell surface tissue transglutaminase is involved in adhesion and migration of monocytic cells on fibronectin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Self-renewal and solid tumor stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Transforming growth factor-beta isoform expression in human ovarian tumours.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Altered expression of transforming growth factor-beta ligands and receptors in primary and recurrent ovarian carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Tissue transglutaminase protects epithelial ovarian cancer cells from cisplatin-induced apoptosis by promoting cell survival signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

A crucial sequence for transglutaminase type 2 extracellular trafficking in renal tubular epithelial cells lies in its N-terminal beta-sandwich domain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Cellular activation of latent transforming growth factor beta requires binding to the cation-independent mannose 6-phosphate/insulin-like growth factor type II receptor

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Smad-dependent and Smad-independent pathways in TGF-beta family signalling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

HER2/Neu- and TAK1-mediated up-regulation of the transforming growth factor beta inhibitor Smad7 via the ETS protein ER81

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Autocrine transforming growth factor-beta signaling mediates Smad-independent motility in human cancer cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-beta-induced gene expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Identification of a novel recognition sequence for fibronectin within the NH2-terminal beta-sandwich domain of tissue transglutaminase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Disabled-2 (Dab2) mediates transforming growth factor beta (TGFbeta)-stimulated fibronectin synthesis through TGFbeta-activated kinase 1 and activation of the JNK pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Expression and subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in epithelial ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Interaction and functional cooperation of NF-kappa B with Smads. Transcriptional regulation of the junB promoter

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

The epithelial-mesenchymal transition generates cells with properties of stem cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Overexpression of tissue transglutaminase leads to constitutive activation of nuclear factor-kappaB in cancer cells: delineation of a novel pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

TGFbeta signaling: receptors, transducers, and Mad proteins.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Gene expression in epithelial ovarian carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Prognostic significance of tissue transglutaminase in drug resistant and metastatic breast cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

TGF-beta-RI kinase inhibitor SD-208 reduces the development and progression of melanoma bone metastases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelial-mesenchymal transition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Transformation of cell adhesion properties by exogenously introduced E-cadherin cDNA

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Expression and action of transforming growth factor beta (TGFbeta1, TGFbeta2, TGFbeta3) in normal bovine ovarian surface epithelium and implications for human ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

A causal role for E-cadherin in the transition from adenoma to carcinoma

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

The specificity of transglutaminase. II. Structural requirements of the amine substrate

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Transforming growth factor (TGF)-beta-activated kinase 1 mimics and mediates TGF-beta-induced stimulation of type II collagen synthesis in chondrocytes independent of Col2a1 transcription and Smad3 signaling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Regulation of invasion of epithelial ovarian cancer by transforming growth factor-beta

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Enhanced peritoneal ovarian tumor dissemination by tissue transglutaminase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Tissue transglutaminase regulates matrix metalloproteinase-2 in ovarian cancer by modulating cAMP-response element-binding protein activity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Epithelial-to-mesenchymal transition and ovarian tumor progression induced by tissue transglutaminase

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Compact spheroid formation by ovarian cancer cells is associated with contractile behavior and an invasive phenotype.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Epithelial-mesenchymal transitions in tumour progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Consequences of altered TGF-beta expression and responsiveness in breast cancer: evidence for autocrine and paracrine effects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

A SNAIL1-SMAD3/4 transcriptional repressor complex promotes TGF-beta mediated epithelial-mesenchymal transition

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Transforming growth factor-beta1-dependent activation of Smad2/3 and up-regulation of PAI-1 expression is negatively regulated by Src in SKOV-3 human ovarian cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Ovarian carcinoma cell cultures are resistant to TGF-beta1-mediated growth inhibition despite expression of functional receptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Identification of a member of the MAPKKK family as a potential mediator of TGF-beta signal transduction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Zinc transporter LIVI controls epithelial-mesenchymal transition in zebrafish gastrula organizer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Human Smad3 and Smad4 are sequence-specific transcription activators

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Modulation of the in situ activity of tissue transglutaminase by calcium and GTP.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

Identification and characterization of ovarian cancer-initiating cells from primary human tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FONC.2011.429

31 March 2020

Identifiers

DOI

10.1038/ONC.2011.429

1 reference

12 September 2017

1 reference